Abbott Laboratories ABT reported quarterly earnings of 82 cents per share, which beat the analyst consensus estimate of 8 cents. This is a 12.33% increase over earnings of 73 cents per share from the same period last year.
The company reported quarterly sales of $7.98 billion, which missed the analyst consensus estimate of $8 billion. This is a 2.74% increase over sales of $7.767 billion the same period last year.
Abbott Laboratories shares traded up 0.9% at $83.97 in Wednesday’s pre-market session. The stock has a 52-week high of $85.99 and a 52-week low of $61.55.
Related Links:
An Abbott Labs Analyst's 5 Reasons To Own The Stock: 'Near-Perfect For This Environment'
Abbott Labs Has 'An Emerging Picture Of Top-Tier Growth,' Says Morgan Stanley
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.